Pharmacogenomic Decision Support With GeneSight Psychotropic to Guide the Treatment of Major Depressive Disorder

NCT02466477 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

542

Enrollment

INDUSTRY

Sponsor class

Conditions

Depressive Disorder, Major
Depression
Depressive Disorder

Interventions

GENETIC: GeneSight Psychotropic (GEN)
GENETIC: Enhanced-GeneSight Psychotropic (E-GEN)
OTHER: Treatment as Usual (TAU)

Sponsor

Assurex Health Inc.

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]